|1.||Giovanella, Luca: 2 articles (01/2009 - 10/2007)|
|2.||Ferrone, Soldano: 2 articles (01/2005 - 08/2003)|
|3.||Dunmire, Samantha K: 1 article (02/2015)|
|4.||Balfour, Henry H: 1 article (02/2015)|
|5.||Hogquist, Kristin A: 1 article (02/2015)|
|6.||Peuchmaur, Michel: 1 article (01/2015)|
|7.||Monteiro, Renato C: 1 article (01/2015)|
|8.||Madjene, Lydia Celia: 1 article (01/2015)|
|9.||Blank, Ulrich: 1 article (01/2015)|
|10.||Beghdadi, Walid: 1 article (01/2015)|
04/08/1988 - "Experimental animal studies confirmed the in vitro anti-aggregatory efficacy of SC 38249, since significant inhibitory activity was observed against Paf-acether and ADP-induced responses in dog PRP ex vivo, anti-Forssman antibody-induced thrombocytopenia in anaesthetized guinea pigs, and collagen-induced intravascular aggregation in anaesthetized rabbits. "
01/01/1990 - "The clearance of heterologous antibodies in experimental antibasement membrane antibody mediated glomerulonephritis."
01/01/2015 - "To investigate the mechanisms of disease development in glomerulonephritis various animal models have been developed, which include as the most popular one the induction of glomerulonephritis by the injection of heterologous antibodies directed to the glomerular basement membrane. "
01/01/1999 - "Crescentic glomerulonephritis can be induced in rodents by injection of heterologous antibodies against the glomerular basement membrane. "
01/01/2001 - "There is evidence that crescentic glomerulonephritis initiated in rodents by heterologous antibodies against the glomerular basement membrane (anti-GBM glomerulonephritis) depends on a Th1-type immune reaction. "
10/01/1989 - "An induction of serious renal damage in experimental glomerulonephritis demands a chronic supply of antigen, rarely seen in human glomerulonephritis; or the use of heterologous antibodies, a design with questionable clinical relevance; or immuno- and nephrotoxic chemicals; or Freund's adjuvant which is also nephrotoxic. "
10/01/1958 - "Studies on the heterophile antibodies associated with helminth infections. "
07/01/1958 - "Studies on the heterophile antibodies associated with helminth infections. "
01/01/1958 - "Studies on the heterophile antibodies associated with helminth infections. "
12/01/2014 - "For secondary infections with a different serotype, the homologous antibody production is enhanced due to the influence of heterologous antibodies. "
02/01/2011 - "Preexisting heterotypic antibodies, via their Fc-gamma receptor (FcγR) interactions, may increase disease severity through enhanced target cell infection. "
|4.||Infectious Mononucleosis (Glandular Fever)
04/01/2009 - "The aim of this study was to evaluate the sensitivity and the specificity of a rapid test detecting heterophil antibodies in diagnosing infectious mononucleosis in a paediatric population. "
11/01/1990 - "The purpose of this study was to compare not only the two different test systems but also the two different methods they represent for accuracy in detecting infectious mononucleosis-specific heterophil antibodies. "
11/01/1990 - "The present study evaluated the Ventrescreen Mono enzyme immunoassay (Ventrex Laboratories) and Monolatex (Wampole Laboratories) for detection of infectious mononucleosis-specific heterophil antibodies by comparing test results on sera of 247 symptomatic patients. "
12/01/1977 - "Studies on the heterophile antibodies of infectious mononucleosis. "
02/01/2015 - "A typical clinical picture in an adolescent or young adult with a positive heterophile test is usually sufficient to make the diagnosis of infectious mononucleosis, but heterophile antibodies are not specific and do not develop in some patients especially young children. "
|5.||Melanoma (Melanoma, Malignant)
08/01/2003 - "Immunohistochemical staining with anti-LMP2 and anti-LMP7 xenoantibodies showed a significantly higher expression of these immunoproteasome subunits in primary melanoma lesions exhibiting histological signs of tumour regression than in primary melanoma lesions without regression phenomena. "
01/01/1994 - "The aim of this study was to detect possible immunomodulatory effects of unpurified human alpha-interferon on izohemagglutinin (IZO), and anti-Forssman antibody (AFA) serum levels during a treatment in patients with malignant melanoma. "
02/01/1984 - "Quantities of a 100,000-mol wt human melanoma-associated antigen (MAA), defined by both monoclonal and polyclonal xenoantibodies, were measured in sera of 32 patients with malignant melanoma and 15 carefully documented healthy volunteers by use of an amplified sandwich enzyme-linked immunoabsorbent assay. "
02/01/1981 - "Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens."
07/01/2001 - "The possible clinical applications of Neu5Gc-containing glycoconjugates and Hanganutziu-Deicher antibodies in the diagnosis and treatment of breast cancer and melanoma are also discussed. "
|1.||Platelet Activating Factor
|3.||Adenosine Diphosphate (ADP)
|4.||1- (2,3- bis((4- methoxyphenyl)methoxy)propyl)- 1H- imidazole
|7.||Immunoglobulin G (IgG)
|8.||Immunoglobulin M (IgM)
|10.||Antigen-Antibody Complex (Immune Complex)
|4.||Heterologous Transplantation (Xenotransplantation)
|5.||Transplantation (Transplant Recipients)